Related Experiment Video
Updated: Sep 17, 2025
11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
46.9K
Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and Treatment
Oncology (Williston Park, N.Y.)
|July 2, 2025
Summary
Breast cancer treatments can cause heart problems (cardiotoxicity). This review covers risk assessment, monitoring, and management strategies to improve cardiovascular health in cancer patients.
Area of Science:
- Oncology
- Cardiology
- Cancer Therapeutics
- Cardiovascular Disease
Background:
- Long-term breast cancer survival is improving due to early detection and advanced therapeutics.
- Cardiovascular disease (CVD) is a primary cause of non-cancer mortality in breast cancer survivors.
- Treatment-related cardiotoxicity from chemotherapy and radiation, alongside shared risk factors, contributes to CVD.
Purpose of the Study:
- To provide an overview of cardiotoxicities associated with common breast cancer treatments.
- To present risk-stratification tools for identifying patients at risk of treatment-related cardiotoxicity.
- To review current and future strategies for preventing and managing cardiotoxicity in breast cancer patients.
Main Methods:
- Literature review of treatment-related cardiotoxicities in breast cancer.
- Analysis of risk-stratification tools and cardiovascular testing recommendations.
- Review of recent clinical trial data on preventive and therapeutic approaches.
Main Results:
- Common breast cancer treatments pose significant risks for cardiovascular toxicity.
- Risk-stratification tools and tailored cardiovascular testing can aid in early identification.
- Emerging preventive and therapeutic strategies show promise for mitigating cardiotoxicity.
Conclusions:
- Identifying and managing treatment-related cardiotoxicity is crucial for improving long-term outcomes in breast cancer patients.
- Multidisciplinary collaboration between oncologists and cardiologists is essential for optimal patient care.
- Further research into novel therapeutic and preventive strategies is needed to enhance cardiovascular health in this population.
Related Concept Videos
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
01:29Cardiomyopathy VI: Nursing Management
47
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
47
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
30
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
30
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K